Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention

BACKGROUND: In patients undergoing percutaneous coronary intervention (PCI) in the SMART-CHOICE trial, P2Y12 inhibitor monotherapy after three months of dual antiplatelet therapy (DAPT) achieved clinical outcomes comparable to those of 12 months of DAPT. Nonetheless, the effects of sex on these outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Eun-Seok, Her, Ae-Young, Kim, Bitna, Hahn, Joo-Yong, Song, Young Bin, Lee, Joo Myung, Park, Taek Kyu, Yang, Jeong Hoon, Choi, Jin-Ho, Choi, Seung-Hyuk, Lee, Sang Hoon, Gwon, Hyeon-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659928/
https://www.ncbi.nlm.nih.gov/pubmed/37987108
http://dx.doi.org/10.3346/jkms.2023.38.e383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659928/
https://www.ncbi.nlm.nih.gov/pubmed/37987108
http://dx.doi.org/10.3346/jkms.2023.38.e383

Ejemplares similares